COTELLIC: payments to doctors
Payments that named COTELLIC as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
Was your doctor paid by F. Hoffmann-la Roche AG?
F. Hoffmann-la Roche AG reported the most payments naming COTELLIC. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $80K
- Providers
- 32
- Transactions
- 58
- Average per transaction
- $1,376
The per-transaction average — $1,376 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 32 providers the average total is $2,494, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| F. Hoffmann-la Roche AG | $70,744 | 88.6% |
| Genentech, Inc. | $5,972 | 7.5% |
| Genentech USA, Inc. | $2,441 | 3.1% |
| Exelixis Inc. | $649 | 0.8% |
| Roche Products Limited | $14 | 0.0% |
Other products from F. Hoffmann-la Roche AG
The company that reported the most payments naming COTELLIC also reports against these.